Dexin China Holdings Completes US$189 Million Hong Kong IPO

February 26, 2019

Hong Kong – Paul Hastings, a leading global law firm, announced today that the firm has advised CCB International Capital Limited as the sole sponsor and sole global coordinator on Dexin China Holdings Company Limited’s (“Dexin China”) US$189 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange.

Dexin China is a leading comprehensive property developer based in Zhejiang Province, China, focusing primarily on the development of residential properties and the development, operation and management of commercial and mixed-use properties.

Paul Hastings has acted in some of the most significant Chinese property company listings in Hong Kong in recent years, including listings by

, and .

The Paul Hastings team was led by

, global partner and Chair of Greater China practice, and capital markets partner , with support from associates , and , trainee solicitor and paralegal Ariel Lu, Jingwei Huang and Bixia Chen.

At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.

Practice Areas



Corporate, Litigation, Real Estate, Intellectual Property, Life Sciences, and Employment
Becca Hatton
Katy Foster
Miranda Ward
Submission Requests
Firmwide Inquiries
Elliott Frieder

Get In Touch With Us

Contact Us